Novavax Inc (NVAX) Stock Price, Quote & News

Company Profile

Novavax, Inc., a biotechnology company, engages in the discovery, development, and commercialization of vaccines to prevent serious infectious diseases in the United States, Europe, and internationally. The company commercializes Nuvaxovid, a COVID-19 vaccine; and R21 Matrix-M adjuvant malaria vaccine. It has license and collaboration agreements with Sanofi, Pfizer Inc., Takeda Pharmaceutical Company Limited, and Serum Life Sciences Limited for the to develop, manufacture, and commercialize the...

Industry: Biotechnology

Sector: Healthcare

Phone: 240 268 2000

Website: www.novavax.com

Address:

21 Firstfield Road, Gaithersburg, United States

DarvasBoxing Aug. 24 at 11:00 PM

$NVAX

0 · Reply

P38FTD Aug. 24 at 9:44 PM

$NVAX Bancel was on Fox Business this morning. Didn’t bother watching the bs. Besides, there’s still work to do on my deck. I’ll let you know when we’re both finished.

0 · Reply

ddirk Aug. 24 at 9:03 PM

$NVAX being that Trump had hand in it I’m not surprised about all the corruption

0 · Reply

Bodu Aug. 24 at 8:45 PM

$NVAX LOL. You could actually do 6.5% if you were following your own advice to buybthe deep.

2 · Reply

Biotechlineup Aug. 24 at 8:24 PM

$NVAX I very rarely like to promote other stocks , especially on a different board. We have to look at the really big picture. I discovered Bctx when doing my research on what immuno oncology companies would benefit from Matrix M. The obvious was Merck, however I came up with what seemed like a Crazy idea that most still don’t understand. Still don’t see anyone anywhere on the internet discussing matrix m with mRNA or the Bctx platform. Anyone else find anything? Well the science is real , Bctx validation and has a very good melanoma cancer vaccine . Guess what will supercharge Bctx platform? Yes Matrix M, mRNA ? Yes matrix m. In time I will be proven right.

0 · Reply

Zeger Aug. 24 at 7:59 PM

$NVAX nice come back today. Shorts seem to be losing steam. Time for double digits once again!

0 · Reply

Moneymaker420_69 Aug. 24 at 7:58 PM

$NVAX GUYS can my predicksion be correct ?

1 · Reply

Moneymaker420_69 Aug. 24 at 7:55 PM

$NVAX I love this stonk 🥰🥰

1 · Reply

the_wulf Aug. 24 at 7:29 PM

$NVAX 9$ 11$ 12$

0 · Reply

DrSammy Aug. 24 at 7:25 PM

$NVAX This is a machine ( or Collection of Machines) that react aggressively to certain (Harmonic Structures)/ABC Waves (Very aggressively to C waves both on bullish and bearish patterns). It calculates risk, exposure, derivative bets/straddles, builds structures/patterns ('if you build it they'll come') w/ accuracy that sometimes make the outcome 'predictable' -- that's just for Fun & Entertainment for non-believers They're making a fortune from Transaction fees, lending Contracts, rates, arbitrage transactions, derivative bets/transactions, ETFs and god know what else! :)

3 · Reply

Novavax Earnings Call Transcript: Q2 2026

Aug 6, 2026, 8:30 AM EDT - 18 days ago

Novavax Quarterly report: Q2 2026

Aug 6, 2026, 8:30 AM EDT - 18 days ago

Novavax Earnings release: Q2 2026

Aug 6, 2026, 8:30 AM EDT - 18 days ago

Novavax Slides: Q2 2026

2026-08-06T12:22:31.000Z - 18 days ago

Novavax reports Q2 EPS (32c), consensus (38c)

2026-08-06T12:21:31.000Z - 18 days ago

Novavax raises 2026 adjusted revenue view to $235M-$275M from $230M-$270M

Aug 6, 2026, 8:04 AM EDT - 18 days ago

Novavax lifts annual revenue forecast as licensing bets offset weak vaccine demand

Aug 6, 2026, 8:00 AM EDT - 18 days ago

Novavax Reports Second Quarter 2026 Financial Results and Operational Highlights

Jul 30, 2026, 7:00 AM EDT - 25 days ago

Novavax to Report Second Quarter 2026 Financial Results on August 6, 2026

2026-07-10T15:15:11.000Z - 6 weeks ago

Novavax put volume heavy and directionally bearish

Jun 24, 2026, 8:00 AM EDT - 2 months ago

Shah Capital Responds to Significant Shareholder Dissent at Novavax AGM

2026-06-22T15:15:08.000Z - 2 months ago

Novavax put volume heavy and directionally bearish

Jun 18, 2026, 8:30 AM EDT - 2 months ago

Novavax Transcript: AGM 2026

Jun 4, 2026, 10:30 AM EDT - 2 months ago

Novavax Transcript: Jefferies Global Healthcare Conference 2026

Jun 1, 2026, 4:00 PM EDT - 3 months ago

Novavax to Participate in 2026 Jefferies Global Healthcare Conference

May 13, 2026, 6:40 PM EDT - 3 months ago

Novavax Transcript: Bank of America Global Healthcare Conference 2026

May 12, 2026, 7:00 AM EDT - 3 months ago

Novavax Slides: Corporate presentation

May 11, 2026, 7:53 AM EDT - 3 months ago

Hantavirus cases spark surge in pharma and biotech stocks — here's why

EBS INO MRNA

May 7, 2026, 4:00 PM EDT - 3 months ago

Novavax to Participate in BofA Securities 2026 Health Care Conference

May 6, 2026, 8:30 AM EDT - 3 months ago

Novavax Earnings Call Transcript: Q1 2026

May 6, 2026, 8:30 AM EDT - 3 months ago

Novavax Quarterly report: Q1 2026

May 6, 2026, 8:30 AM EDT - 3 months ago

Novavax Earnings release: Q1 2026

May 6, 2026, 8:30 AM EDT - 3 months ago

Novavax Slides: Q1 2026

May 6, 2026, 8:00 AM EDT - 3 months ago

Novavax Reports First Quarter 2026 Financial Results and Operational Highlights

May 6, 2026, 7:56 AM EDT - 3 months ago

Novavax beats first-quarter revenue estimates on vaccine deals strength

Apr 29, 2026, 4:00 PM EDT - 4 months ago

Novavax to Report First Quarter 2026 Financial Results on May 6, 2026

Apr 27, 2026, 8:00 AM EDT - 4 months ago

Novavax Proxy statement: Proxy filing

Apr 27, 2026, 8:00 AM EDT - 4 months ago

Novavax Proxy statement: Proxy filing

Apr 8, 2026, 6:08 AM EDT - 4 months ago

Shah Capital intends to vote against Novavax's board nominees, executive compensation

Mar 30, 2026, 8:00 AM EDT - 5 months ago

Novavax Appoints Dr. Robert Walker as Executive Vice President and Head of Research & Development

Mar 10, 2026, 3:40 PM EDT - 5 months ago

Novavax Transcript: Leerink Global Healthcare Conference 2026

Mar 3, 2026, 2:30 PM EST - 6 months ago

Novavax Transcript: TD Cowen 46th Annual Health Care Conference

Feb 26, 2026, 4:30 PM EST - 6 months ago

Novavax to Participate in Upcoming Investor Conferences

Feb 26, 2026, 8:30 AM EST - 6 months ago

Novavax Earnings Call Transcript: Q4 2025

Feb 26, 2026, 8:30 AM EST - 6 months ago

Novavax Earnings release: Q4 2025

Feb 26, 2026, 8:30 AM EST - 6 months ago

Novavax Annual report: Q4 2025

Feb 26, 2026, 8:30 AM EST - 6 months ago

Novavax Slides: Q4 2025

Feb 26, 2026, 8:06 AM EST - 6 months ago

Novavax raises 2026 adjusted revenue outlook on strength in vaccine deals

Feb 26, 2026, 8:00 AM EST - 6 months ago

Novavax Reports Fourth Quarter and Full Year 2025 Financial Results and Operational Highlights

Feb 19, 2026, 8:00 AM EST - 6 months ago

Novavax to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026

Jan 20, 2026, 7:15 AM EST - 7 months ago

Novavax Announces Entering into a License Agreement with Pfizer

Jan 20, 2026, 7:11 AM EST - 7 months ago

Novavax enters license agreement with Pfizer for vaccine development

PFE

Jan 14, 2026, 7:30 PM EST - 7 months ago

Novavax Transcript: 44th Annual J.P. Morgan Healthcare Conference

Jan 14, 2026, 7:30 PM EST - 7 months ago

Novavax Slides: 44th Annual J.P. Morgan Healthcare Conference

Jan 7, 2026, 8:00 AM EST - 8 months ago

Novavax to Participate in the 44th Annual J.P. Morgan Healthcare Conference

Dec 1, 2025, 3:50 PM EST - 9 months ago

FDA Plans to Tighten Vaccine Approvals Weigh on These Stocks

BNTX MRNA PFE

Dec 1, 2025, 12:35 PM EST - 9 months ago

Vaccine stocks take a hit as FDA official points to link between COVID-19 vaccines and rare heart condition in young men

BNTX MRNA PFE

Dec 1, 2025, 9:59 AM EST - 9 months ago

Moderna and Novavax Stocks Drop as FDA Proposes Stricter Vaccine Approvals

MRNA

Nov 19, 2025, 11:30 AM EST - 9 months ago

Novavax Transcript: Jefferies London Healthcare Conference 2025

Nov 12, 2025, 4:41 PM EST - 10 months ago

Shah Capital pushes for Novavax sale, warns of proxy fight

Nov 12, 2025, 8:00 AM EST - 10 months ago

Novavax to Participate in Jefferies London Healthcare Conference

Nov 6, 2025, 8:30 AM EST - 10 months ago

Novavax Earnings Call Transcript: Q3 2025

Nov 6, 2025, 8:30 AM EST - 10 months ago

Novavax Earnings release: Q3 2025

Nov 6, 2025, 8:30 AM EST - 10 months ago

Novavax Quarterly report: Q3 2025

Nov 6, 2025, 8:30 AM EST - 10 months ago

Novavax Slides: Q3 2025

Nov 6, 2025, 8:00 AM EST - 10 months ago

Novavax Reports Third Quarter 2025 Financial Results and Operational Highlights

Nov 6, 2025, 7:58 AM EST - 10 months ago

Novavax raises annual revenue forecast on strength of vaccine deals

Nov 4, 2025, 7:00 AM EST - 10 months ago

Novavax Completes U.S. Marketing Authorization Transfer to Sanofi for Nuvaxovid™, Triggering a $25 Million Milestone Payment

Oct 30, 2025, 8:00 AM EDT - 10 months ago

Novavax to Report Third Quarter 2025 Financial Results on November 6, 2025

Oct 22, 2025, 7:00 AM EDT - 10 months ago

Novavax Executes Planned Site Consolidation, Further Reducing Cost Footprint in Line with Corporate Strategy

Oct 14, 2025, 6:09 AM EDT - 11 months ago

Shah Capital pushes for Novavax's sale on persistent underperformance, marketing missteps

Oct 7, 2025, 7:00 AM EDT - 11 months ago

Novavax Continues to Deliver on Sanofi Partnership, Completing Nuvaxovid® EU Marketing Authorization Transfer and Triggering $25 Million Milestone Payment

Sep 30, 2025, 9:01 AM EDT - 11 months ago

Novavax Announces Progress on Sanofi Agreement

Sep 19, 2025, 11:40 AM EDT - 1 year ago

Mizuho's Jared Holz: There's not much value left in vaccine stocks

BNTX MRNA PFE

Sep 4, 2025, 10:20 AM EDT - 1 year ago

Novavax Transcript: Cantor Global Healthcare Conference 2025

Sep 4, 2025, 8:00 AM EDT - 1 year ago

Nuvaxovid® Now Approved in Japan Triggering Takeda Milestone Payment

Sep 3, 2025, 8:00 AM EDT - 1 year ago

Novavax to Participate in the Cantor Global Healthcare Conference

Aug 27, 2025, 3:07 PM EDT - 1 year ago

Novavax's Nuvaxovid™ 2025-2026 Formula COVID-19 Vaccine Approved in the U.S.

Aug 21, 2025, 7:43 AM EDT - 1 year ago

Novavax Announces Convertible Debt Refinancing

Aug 6, 2025, 8:30 AM EDT - 1 year ago

Novavax Earnings Call Transcript: Q2 2025

Aug 6, 2025, 8:30 AM EDT - 1 year ago

Novavax Earnings release: Q2 2025

Aug 6, 2025, 8:30 AM EDT - 1 year ago

Novavax Quarterly report: Q2 2025

Aug 6, 2025, 8:30 AM EDT - 1 year ago

Novavax Slides: Q2 2025

Aug 6, 2025, 8:08 AM EDT - 1 year ago

Novavax beats quarterly revenue estimates on milestone payment

Aug 6, 2025, 8:00 AM EDT - 1 year ago

Novavax Reports Second Quarter 2025 Financial Results and Operational Highlights

Jul 30, 2025, 8:00 AM EDT - 1 year ago

Novavax to Report Second Quarter 2025 Financial Results on August 6, 2025

Jul 24, 2025, 8:00 AM EDT - 1 year ago

Novavax's H5N1 Vaccine Candidate Demonstrates Immunogenicity in Preclinical Study

Jun 11, 2025, 2:00 PM EDT - 1 year ago

Novavax Transcript: Goldman Sachs 46th Annual Global Healthcare Conference

Jun 11, 2025, 2:00 PM EDT - 1 year ago

Novavax Slides: Goldman Sachs 46th Annual Global Healthcare Conference

Jun 11, 2025, 7:11 AM EDT - 1 year ago

Novavax's COVID-flu combo and standalone flu shots improve immunity in late-stage study

Jun 11, 2025, 7:00 AM EDT - 1 year ago

Novavax's COVID-19-Influenza Combination and Stand-alone Influenza Vaccine Candidates Showed Robust Immune Responses and Were Well Tolerated in Initial Cohort of a Phase 3 Trial

Jun 10, 2025, 10:45 AM EDT - 1 year ago

Vaccine actions and policy positions under US Health Secretary Kennedy

BNTX MRNA PFE

Jun 10, 2025, 9:30 AM EDT - 1 year ago

Vaccine stocks muted as Wall Street takes 'wait and watch' approach after Kennedy's shake-up

BNTX MRNA PFE

Jun 10, 2025, 8:18 AM EDT - 1 year ago

Why Moderna, Pfizer Stocks Are Shrugging Off RFK Jr.'s Firing of Vaccine Advisors.

BNTX MRNA PFE SNY

May 20, 2025, 4:34 PM EDT - 1 year ago

Healthy Returns: Novavax scores narrower Covid vaccine approval after delay

May 19, 2025, 12:15 PM EDT - 1 year ago

Top Stock Movers Now: Tesla, AutoZone, Novavax, and More

AZO TSLA

May 19, 2025, 9:27 AM EDT - 1 year ago

Novavax Stock Rockets. FDA Finally Had Good News for the Covid-19 Vaccine Maker.

May 19, 2025, 7:16 AM EDT - 1 year ago

Novavax shares jump after long-awaited FDA approval of its COVID-19 vaccine

DarvasBoxing Aug. 24 at 11:00 PM

$NVAX

0 · Reply

P38FTD Aug. 24 at 9:44 PM

$NVAX Bancel was on Fox Business this morning. Didn’t bother watching the bs. Besides, there’s still work to do on my deck. I’ll let you know when we’re both finished.

0 · Reply

ddirk Aug. 24 at 9:03 PM

$NVAX being that Trump had hand in it I’m not surprised about all the corruption

0 · Reply

Bodu Aug. 24 at 8:45 PM

$NVAX LOL. You could actually do 6.5% if you were following your own advice to buybthe deep.

2 · Reply

Biotechlineup Aug. 24 at 8:24 PM

0 · Reply

Zeger Aug. 24 at 7:59 PM

$NVAX nice come back today. Shorts seem to be losing steam. Time for double digits once again!

0 · Reply

Moneymaker420_69 Aug. 24 at 7:58 PM

$NVAX GUYS can my predicksion be correct ?

1 · Reply

Moneymaker420_69 Aug. 24 at 7:55 PM

$NVAX I love this stonk 🥰🥰

1 · Reply

the_wulf Aug. 24 at 7:29 PM

$NVAX 9$ 11$ 12$

0 · Reply

DrSammy Aug. 24 at 7:25 PM

3 · Reply

Novasqueeze Aug. 24 at 7:21 PM

$NVAX so I hope no one bought bctx as it went down 13% today. Maybe not the best stock 😅? Why down so much mr @Biotechlineup

1 · Reply

vsholding Aug. 24 at 7:06 PM

$NVAX

0 · Reply

Flo6 Aug. 24 at 6:56 PM

$NVAX why still <20?!

1 · Reply

jbone13 Aug. 24 at 6:52 PM

$NVAX got to love this crap. Drops 6% in 20 minutes. Takes all damn day to recover 4%

1 · Reply

LouAlwaysKnew Aug. 24 at 6:49 PM

$NVAX The government created the virus The government created the mrna The government created the SEC Novavax got abused by the government Big pharma, wall street and gov big wigs got rich No coincidence

1 · Reply

Pissed_of_retards2 Aug. 24 at 6:15 PM

$NVAX we need at least 100k retail traders ready to put $10K = $1B value on good news to start some nice short squeze

1 · Reply

chloeworld5 Aug. 24 at 5:23 PM

$NVAX when are they going to say something? What the hell are they doing now? Silence never stops.

2 · Reply

Pissed_of_retards2 Aug. 24 at 5:23 PM

$NVAX this endless waiting is madhouse

2 · Reply

DrSammy Aug. 24 at 5:05 PM

$NVAX VANGUARD is the Top Dog Now! Sum of its holdings: 14.865,445 33M shares in ETFs, XBI HOLDS 8M (StateSt: Authorized Agent) No ‘more’ ATMs : Expired Institutional Holdings : ~ 76% based on 13D/F/Gs

1 · Reply

Victory777777 Aug. 24 at 4:36 PM

$NVAX Never set stop loss on a good company stock. Set up higher prices for selling $100

2 · Reply

amnlla Aug. 24 at 4:07 PM

$NVAX As usual, the shorts launched another short attack and took out everyone’s stop-losses along the way. In the end, the shorts covered their positions, while those with stop-losses got completely wiped out.

1 · Reply

ajbski Aug. 24 at 3:46 PM

$NVAX Clinical trials using Matrix-M™ adjuvant for PANDEMIC INFLUENZA include the following three specific programs: •Sanofi & Novavax Bird Flu Vaccine: A Phase 1/2 program utilizing Matrix-M with Sanofi's vaccine candidates against Highly Pathogenic Avian Influenza, backed by BARDA. •Sanofi: H5N8 Trial (NCT07779408): An Active Phase 1/2 observer-blind study testing egg-based H5N8 vaccine doses with and without Matrix-M in healthy adults for dose-sparing. •Historical H5N1 Virosomal Trial: A Completed Phase 1 study showing that Matrix-M safely triggered robust cross-reactive antibodies at a highly reduced antigen dose (1.5 μg). https://share.google/aimode/Ye75nZmbYLFdvEdXh

1 · Reply

Market Cap	1.47B
Revenue (ttm)	1.12B
Net Income (ttm)	440.30M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	39.19%
Debt to Equity Ratio	-1.53

Volume	5,576,600
Avg Vol	3,950,880
Day's Range	N/A - N/A
Shares Out	164.95M
Stochastic %K	82%
Beta	2.46
Analysts	Sell
Price Target	$13.45